| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $5.5B | $5.2B | $5.0B |
| Cost of Revenue | $2.2B | $2.1B | $2.1B |
| Gross Profit | $3.3B | $3.1B | $2.9B |
| R&D Expense | $0.3B | $0.3B | $0.2B |
| SG&A Expense | $1.8B | $1.6B | $1.5B |
| Operating Income | $1.3B | $1.2B | $1.1B |
| Net Income | $0.9B | $0.8B | $0.8B |
| EPS (Basic) | $3.79 | $3.37 | $3.41 |
| EPS (Diluted) | $3.76 | $3.34 | $3.40 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $7.7B | $6.4B | $5.7B |
| Current Assets | $3.4B | $2.4B | $2.1B |
| Cash & Equivalents | $2.0B | $1.1B | $0.8B |
| Total Liabilities | — | — | — |
| Current Liabilities | $2.1B | $1.2B | $1.3B |
| Stockholders' Equity | $3.1B | $2.0B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $1.1B | $0.9B | $1.0B |
| Investing Cash Flow | $-0.1B | $-0.4B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.1B | $-0.1B | $-0.1B |